Literature DB >> 24021523

Number of test trials needed for performance stability and interrater reliability of the one leg stand test in patients with a major non-traumatic lower limb amputation.

Morten Tange Kristensen1, Anni Østergaard Nielsen, Ulla Madsen Topp, Berit Jakobsen, Kirsten Juel Nielsen, Helle Gybel Juul-Larsen, Thomas Linding Jakobsen.   

Abstract

INTRODUCTION: Balance is beneficial for daily functioning of patients with a lower limb amputation and sometimes assessed by the one-leg stand test (OLST). The aims of the study were to examine (1) the number of trials needed to achieve performance stability, (2) the interrater reliability of the OLST in patients with a major non-traumatic lower limb amputation, and (3) to provide a test procedure.
METHODS: Thirteen women and 23 men with a mean age (SD) of 67.4 (10.6) years; 19 below-knee and 17 above-knee amputees who performed the OLST at a mean of 14.5 (4.5) days post-amputation. All patients performed five timed OLST-trials with 1-min rest intervals between trials, supervised by a physical therapist, of which 28 included in the reliability-part conducted this twice, separated with a mean of 3.4 (0.78)h. Repeated measures Friedman determined the number of trials needed to ensure stable OLST-scores while the ICC1.1, the standard error of measurement (SEM) and the smallest real difference (SRD) determined reproducibility.
RESULTS: No learning curve was found for the five OLST-trials (p=0.241), with the best of the five trials reaching a median (25-75% quartile) of 2.9 (1.7-8.2)s, and with only six patients able to stand for more than 10s. The ICC (95% CI), SEM and SRD were respectively 0.87 (0.61-0.96), 0.99 s and 2.74 s.
CONCLUSION: Findings suggest that the best of five trials be used for the OLST in unilateral non-traumatic amputee patients as we found excellent interrater reliability and acceptable agreement when using this score.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amputation; Balance; Number of test trials, Reliability; One-leg-stand-test

Mesh:

Year:  2013        PMID: 24021523     DOI: 10.1016/j.gaitpost.2013.08.017

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  6 in total

1.  A study to assess whether fixed-width beam walking provides sufficient challenge to assess balance ability across lower limb prosthesis users.

Authors:  Andrew Sawers; Brian J Hafner
Journal:  Clin Rehabil       Date:  2017-09-26       Impact factor: 3.477

2.  The required number of trials for biomechanical analysis of a golf swing.

Authors:  Anna C Severin; Sally G Barnes; Stewart A Tackett; C Lowry Barnes; Erin M Mannen
Journal:  Sports Biomech       Date:  2019-01-30       Impact factor: 2.832

3.  Reliability of the Copenhagen Achilles length measure (CALM) on patients with an Achilles tendon rupture.

Authors:  Maria Swennergren Hansen; Morten Tange Kristensen; Thomas Budolfsen; Karen Ellegaard; Per Hölmich; Kristoffer Weisskirchner Barfod
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-08-20       Impact factor: 4.342

4.  Narrowing beam-walking is a clinically feasible approach for assessing balance ability in lower-limb prosthesis users.

Authors:  Andrew Sawers; Brian J Hafner
Journal:  J Rehabil Med       Date:  2018-05-08       Impact factor: 2.912

5.  An enhanced treatment program with markedly reduced mortality after a transtibial or higher non-traumatic lower extremity amputation.

Authors:  Morten T Kristensen; Gitte Holm; Michael Krasheninnikoff; Pia S Jensen; Peter Gebuhr
Journal:  Acta Orthop       Date:  2016-04-18       Impact factor: 3.717

6.  Test-retest reliability and minimal detectable change scores for the short physical performance battery, one-legged standing test and timed up and go test in patients undergoing hemodialysis.

Authors:  Lucía Ortega-Pérez de Villar; Francisco José Martínez-Olmos; Anna Junqué-Jiménez; Juan José Amer-Cuenca; Javier Martínez-Gramage; Tom Mercer; Eva Segura-Ortí
Journal:  PLoS One       Date:  2018-08-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.